Title: Influenza: virus, disease, prevention
1Influenzavirus, disease, prevention control,
treatment
Lecture presented byDr Ghassan Awar02 May 2009
2Virus
3Influenza Virus
Orthomyxovirus
4The Virus
5Types of Influenza Virus
- Three types A, B, C
- Influenza Type A can infect People, birds, pigs,
horses, seals, whales and others - Influenza Type B Human virus
- Not classified according to Subtype
- Cause human epidemics but not pandemics
- Influenza Type C cause mild illness in humans
- Not classified according to subtype
- Do not cause epidemics or pandemics
6Influenza VirusTypes A and B
7Influenza A Virus Subtyping
- Influenza A subtypes are determined by two
surface glycoproteins - Hemagglutinin (HA)
- Neuraminidase (NA)
- 16 HAs and 9 NAs
8Species Infected by Influenza A, HA and NA
Subtypes
N1
H1
N2
H2
N3
H3
H4
N4
H5
N5
H6
N6
H7
N7
H8
N8
H9
N9
H10
H11
H12
H13
H14
H15,16
9Influenza Nomenclature
Influenza type
Hemagglutinin subtype
Year of isolation
A/Sydney/5/97 (H3N2)
Geographic source
Isolate number
Neuraminidase subtype
10Antigenic Drift
- Point mutations in the hemagglutinin gene cause
minor antigenic changes to HA - Continuous process
- Immunity against one strain may be limited
- Antigenic drift produces new virus strains that
may not be recognized by antibodies to earlier
influenza strains - One of the main reasons why people can get the
flu more than one time (Seasonal epidemics). - one or two of the three virus strains in the
influenza vaccine are updated - 6-8 months process
- Targeted at high-risk (inactivated)
11Antigenic Shift
- new influenza virus that can infect humans and
has (new HA subtype NA) through - Genetic reassortment (human and animal viruses)
- Direct animal (poultry) to human transmission
- if most people have little or no protection
against the new virus - Spread easily from person to person
- Pandemic (worldwide spread) may occur
12How Do Influenza Viruses Become More Pathogenic?
- Antigenic Shift
- Strong selection pressure acting on mutations or
changes in HA or NA - Direct infection in humans
- Re-assortment
- Two different strains of influenza infect the
same host - Reassorted virus emerges
13Examples of Re-assortment and Direct Transmission
Non-human virus
Human virus
RE-ASSORTMENT
Reassortant virus
14Epidemiology Terms
- Endemic
- A disease that occurs at an expected constant
level in a population - Background level
Red line Expected deaths each year
Cécile Viboud, et al. Emerg Infect Dis serial on
the Internet. 2006 Apr. Available from
http//www.cdc.gov/ncidod/EID/vol12no04/05-0695-G2
.htm
15Epidemiology Terms
- Epidemic
- When the cases of a disease exceed what is
normally expected - Pandemic
- An epidemic that occurs over a large geographic
area, or across the whole world
16Seasonal Epidemics vs. Pandemics
- Seasonal Influenza
- A public health problem each year
- Usually some immunity built up from previous
exposures to the same subtype - Infants and elderly most at risk
- Influenza Pandemics
- Appear in the human population rarely and
unpredictably - Human population lacks any immunity
- All age groups, including healthy young adults
17Seasonal Epidemics vs. Pandemics
- Seasonal Influenza
- A public health problem each year
- Usually some immunity built up from previous
exposures to the same subtype - Infants and elderly most at risk
- Influenza Pandemics
- Appear in the human population rarely and
unpredictably - Human population lacks any immunity
- All age groups, including healthy young adults
18Prerequisites for pandemic influenza
A new influenza virus emerges to which the
general population has little/no immunity
The new virus must be able to replicate in humans
and cause disease
The new virus must be efficiently transmitted
from one human to another
19Disease
20Chain of Infection
Sensitive host
21Avian Influenza precautions
Contact precautions
Droplet precautions
Airborne Precautions
22Transmission of Influenza Viruses
23Routes of TransmissionDroplet
- Large droplets within 1 meter transmit
- infection via
- Coughing, sneezing, talking
- Medical procedures
24Routes of TransmissionAirborne (droplet nuclei)
- Very small particles of evaporated
- droplets or dust with infectious agent
- may..
- Remain in air for a long time
- Travel farther than droplets
- Become aerosolized during procedures
25General Information
26Signs and Symptoms
27Complications
- Seasonal Influenza
- Ear infection, sinusitis
- Bronchitis, bronchiolitis
- Pneumonia
- viral or secondary bacterial
- Exacerbation of chronic conditions
- Muscle inflammation
- Neurologic Disease
- Seizures
- Brain inflammation
- Reyes syndrome
28Prevention and control
29- Pharmaceutical interventions
- Vaccination
- Chemoprophylaxis
- Non-pharmaceutical interventions NPI
30Seasonal Vaccine
- Primary means of preventing influenza
- Proven efficacy / effectiveness to prevent
infection, severe illness (hospitalization) and
death - Cost effective in many target groups, Safe,
- Generally safe
- 350 million doses produced annually (5 of 6.7
billion population) - Production and consumption highly localized.
- gt95 produced in 9 countries (gt65 in Europe)
- 12 of population use 62 of vaccine
- Production dependent on eggs
- Very little surge capacity
- 2006 estimate
31Influenza Vaccine Benefits
- Can match a seasonal vaccine with a circulating
strain - Can be highly effective for prevention of
seasonal influenza - Vaccination of rapid responders reduces the risk
of infection and prevents viral reassortment
32Non-pharmaceutical Interventions
1. Delay disease transmission and outbreak
peak 2. Decompress peak burden on healthcare
infrastructure 3. Diminish overall cases and
health impacts
33Overview of NPI
- Community level
- Quarantine of groups/sites
- Measures to increase social distance
- School closures
- Business and market closure
- Cancellation of events
- Movement restrictions
- Infection control
- Individual level
- Isolation
- Quarantine
- Infection control
34Voluntary Isolation
- Separation and restricted movement of ill persons
with contagious disease (often in a hospital
setting and Primarily individual level) - Isolate severe and mild cases
- Location of isolation (home, hospital) depends on
several factors (severity of illness, the number
of affected persons, the domestic setting) - Do not wait for lab confirmation
- Plan for large number of severe cases
- Provide medical and social care
35Voluntary Quarantine
- Separation and restricted movement of well
persons presumed exposed - Identification of contacts
- Often at home, but may be designated residential
facility or hospital - Applied at the individual or community level
- Regular health monitoring is essential part of
quarantine - Self-health monitoring and reporting
36Infection Control
- Hand hygiene
- Cough etiquette
- Facemasks
37Hand Washing
- Method
- Wet hands with clean (not hot) water
- Apply soap
- Rub hands together for at least 20 seconds
- Rinse with clean water
- Dry with disposable towel or air dry
- Use towel to turn off faucet
38Alcohol-based Hand Rubs
- Effective if hands not visibly soiled
- More costly than soap water
- Method
- Apply appropriate (3ml) amount to palms
- Rub hands together, covering all surfaces until
dry
39Cough etiquette
- Respiratory etiquette
- Cover nose / mouth when coughing or sneezing
- Hand washing!
40Patients Cared for at Home
- Potential for transmission
- Must educate family caregivers
- Fever / symptom monitoring
- Infection control measures
- Hand washing
- Use of available material as mask
41Treatment
42Case Management
- Antivirals
- Consider age group
- Supportive care
- Antibiotics
43Anti-viral Drugs Classes of Influenza Specific
Antivirals
- Neuraminidase inhibitors
- Oseltamivir (Tamiflu)
- Zanamivir (Relenza)
- Adamantanes
- Amantadine
- Rimantadine
Primary drug for mass chemoprophylaxis and for
treating human cases of avian influenza.
44Neuraminidase Inhibitor
- Two drugs available
- Oseltamivir and zanamivir
- Should be given as soon as possible
- Effective for treatment and prevention
- Used for seasonal, avian and swine influenza
45Oseltamivir Treatment in Seasonal Influenza (5
days)
- Adults
- 75 mg twice a day for 5 days
- Children
-
- lt1 year, not studied adequately
- lt 15 kg - 30 mg twice a day
- gt15 kg to lt23 kg - 45 mg twice a day
- gt23 kg to lt40 kg - 60 mg twice a day
- gt40 kg - 75 mg twice a day
46Zanamivir
- Inhaled by mouth via special device
- May be used for gt 5 years of age
- Unstudied in human H5N1 illness
- Treatment dosage
- 2 inhalations (10 mg), once in morning and
night for 5 days - Side effects
- Wheezing, and breathing problems